FTC, HHS Seek Public Comment on Generic Drug Shortages and Competition Amongst Powerful Middlemen
In the Request for Information (RFI), the FTC and HHS are seeking public comment regarding market concentration among large health care GPOs and drug wholesalers, as well as information detailing their contracting practices.
- In the Request for Information (RFI), the FTC and HHS are seeking public comment regarding market concentration among large health care GPOs and drug wholesalers, as well as information detailing their contracting practices.
- The joint RFI is asking these questions to help uncover the root causes and potential solutions to drug shortages.
- “Our inquiry requests information on the factors driving these shortages and scrutinizes the practices of opaque drug middlemen.
- - Whether and to what extent concentration among GPOs and drug wholesalers has disincentivized suppliers from competing in generic drug markets.